APOA1 and cardiovascular disorder: There is a growing body of evidence indicating that apoB/apoA-1 is a powerful biomarker of future cardiovascular disease as it impacts lipid metabolism, and is a marker of inflammation possessing both anti-oxidant and anti-inflammatory effects.